Face-Down Positioning Duration for Macular Hole Repair
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment 'Face-Down Positioning Duration for Macular Hole Repair'?
Research shows that shortening face-down positioning from 1 week to 3 days does not significantly affect the success rate of macular hole surgery. Additionally, some studies suggest that avoiding strict face-down positioning can still achieve similar closure rates, indicating flexibility in post-surgery positioning may be effective.12345
Is face-down positioning after macular hole surgery safe for humans?
How does face-down positioning duration for macular hole repair differ from other treatments?
Face-down positioning after macular hole surgery is unique because it involves patients lying face-down for a specific duration to help the hole heal. This treatment can vary in duration, with some studies suggesting shorter periods like 3 days may be as effective as longer periods like 7 days, making it potentially more comfortable and less burdensome for patients.12347
What is the purpose of this trial?
A full-thickness macular hole is when there is a small gap that opens in the center part of the retina (the light-sensitive layer of tissue in the back of the eye). Following surgical repair of these holes, patients have to lie face down for a number of days and nights. The exact amount of time necessary to position is however unknown. The goal of this randomized feasibility clinical trial is to compare 3 days and nights of face-down positioning to 7 days and nights of face-down positioning following pars plana vitrectomy surgery for full-thickness macular holes on key patient outcomes. This study will be a feasibility study to better inform a future larger clinical trial. Additionally, this investigation will be examining the rates of macular hole closure, patient visual acuity following surgery, patient quality of life, patient compliance, and complication rates.
Research Team
Varun Chaudhary, MD, FRCSC
Principal Investigator
McMaster University, St. Joseph's Hospital
Eligibility Criteria
This trial is for patients with a recent (less than 6 months) idiopathic full-thickness macular hole. Participants must agree to follow the study procedures, which include lying face down for several days after eye surgery.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo pars plana vitrectomy surgery followed by face-down positioning for either 3 or 7 days and nights
Follow-up
Participants are monitored for macular hole closure, visual acuity, quality of life, and complications
Treatment Details
Interventions
- 3 Days of face-down positioning
- 7 Days of face-down positioning
Find a Clinic Near You
Who Is Running the Clinical Trial?
St. Joseph's Healthcare Hamilton
Lead Sponsor